News | September 08, 2023
Fermenta Biotech inaugurates customized premix manufacturing plant in Kullu, Himachal Pradesh
The company will develop and produce premixes for human nutrition applications
The company will develop and produce premixes for human nutrition applications
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
_256_384.jpg)
The collaboration aims to raise awareness about eye cancer, provide medical and surgical treatment support to children and supply nutritional supplements to aid in their faster recovery.
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Agreement provides customers in the majority of Europe* access to supply through Univar Solutions distribution network
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The collaboration between CORONA and Ferring will cater to patients across India
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
Subscribe To Our Newsletter & Stay Updated
